Lee W.-S.PO-REN HSUEHYu F.-L.Chen F.-L.Hsieh T.-C.Ou T.-Y.2020-12-182020-12-1820171684-1182https://scholars.lib.ntu.edu.tw/handle/123456789/528244[SDGs]SDG3amikacin; amoxicillin plus clavulanic acid; ampicillin; cefalexin; cefazolin; cefepime; cefoperazone plus sulbactam; ceftazidime; ciprofloxacin; DNA 16S; doripenem; gentamicin; imipenem; levofloxacin; meropenem; penicillin derivative; antiinfective agent; acute respiratory failure; antibiotic resistance; antibiotic sensitivity; antibiotic therapy; bacteremia; bacterium isolation; blood culture; cancer patient; case report; Comamonas testosteroni; coughing; fever; human; laboratory test; Letter; lung cancer; lung infiltrate; male; Moraxella; Moraxella osloensis; Moraxellaceae infection; pneumonia; positive end expiratory pressure; sequence analysis; thorax radiography; treatment duration; bacterial pneumonia; complication; lung tumor; matrix-assisted laser desorption-ionization mass spectrometry; microbial sensitivity test; molecular diagnosis; multidrug resistance; pathology; radiography; Taiwan; treatment outcome; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Multiple, Bacterial; Humans; Lung Neoplasms; Male; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Moraxella; Moraxellaceae Infections; Pneumonia, Bacterial; Radiography; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Taiwan; Treatment Outcomeletter10.1016/j.jmii.2015.03.005260742822-s2.0-84930814508